SolventumSOLVEarnings & Financial Report
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
Revenue
$2.1B
Gross Profit
$1.1B
Operating Profit
$152.0M
Net Profit
$137.0M
Gross Margin
53.8%
Operating Margin
7.3%
Net Margin
6.6%
YoY Growth
2.7%
EPS
$0.78
Solventum Q1 FY2025 Financial Summary
Solventum reported revenue of $2.1B (up 2.7% YoY) for Q1 FY2025, with a net profit of $137.0M (down 42.2% YoY) (6.6% margin). Cost of goods sold was $956.0M, operating expenses totaled $962.0M.
Key Financial Metrics
| Total Revenue | $2.1B |
|---|---|
| Net Profit | $137.0M |
| Gross Margin | 53.8% |
| Operating Margin | 7.3% |
| Report Period | Q1 FY2025 |
Revenue Breakdown
Solventum Q1 FY2025 revenue of $2.1B breaks down across 5 segments, led by Med Surg Segment at $1.2B (55.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Med Surg Segment | $1.2B | 55.9% |
| Health Information Systems Segment | $329.0M | 15.9% |
| Dental Solutions Segment | $328.0M | 15.8% |
| Purification And Filtration Segment | $242.0M | 11.7% |
| Related Party | $20.0M | 1.0% |
Solventum Revenue by Segment — Quarterly Trend
Solventum revenue by segment across the last 4 reported quarters, showing how each business line (such as Med Surg Segment and Health Information Systems Segment) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Med Surg Segment | — | — | — | $1.2B |
| Health Information Systems Segment | $347.0M | $345.0M | $339.0M | $329.0M |
| Dental Solutions Segment | $343.0M | $340.0M | $338.0M | $328.0M |
| Purification And Filtration Segment | — | $128.0M | $252.0M | $242.0M |
| Related Party | $14.0M | $22.0M | $22.0M | $20.0M |
Solventum Annual Revenue by Year
Solventum annual revenue history includes year-by-year totals (for example, 2025 revenue was $8.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $8.3B |
| 2024 | $8.3B |
Solventum Quarterly Revenue & Net Profit History
Solventum results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $2.0B | -3.7% | $63.0M | 3.2% |
| Q3 FY2025 | $2.1B | +0.7% | $1.3B | 60.4% |
| Q2 FY2025 | $2.2B | +3.8% | $90.0M | 4.2% |
| Q1 FY2025 | $2.1B | +2.7% | $137.0M | 6.6% |
| Q4 FY2024 | $2.1B | — | $31.0M | 1.5% |
| Q3 FY2024 | $2.1B | +0.4% | $122.0M | 5.9% |
| Q2 FY2024 | $2.1B | +0.2% | $89.0M | 4.3% |
| Q1 FY2024 | $2.0B | +0.2% | $237.0M | 11.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.02B | $2.08B | $2.08B | $2.08B | $2.07B | $2.16B | $2.10B | $2.00B |
| YoY Growth | 0.2% | 0.2% | 0.4% | N/A | 2.7% | 3.8% | 0.7% | -3.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.71B | $14.58B | $14.74B | $14.46B | $14.53B | $15.07B | $13.97B | $14.29B |
| Liabilities | $10.86B | $11.71B | $11.55B | $11.50B | $11.27B | $11.43B | $8.99B | $9.24B |
| Equity | $3.85B | $2.87B | $3.19B | $2.96B | $3.26B | $3.65B | $4.99B | $5.05B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $442.0M | $355.0M | $169.0M | $219.0M | $29.0M | $169.0M | $76.0M | $95.0M |